TAPVR Surgical Repair — Procedure Guide, Recovery & Risks | MyMedicPlus

Total anomalous pulmonary venous return (TAPVR) is a rare cyanotic congenital heart defect — accounting for 1-3% of all congenital heart diseases — in which all four pulmonary veins drain into the systemic venous circulation (right atrium, superior vena cava, coronary sinus, or infradiaphragmatic veins below the diaphragm) rather than the left atrium. This means oxygenated blood returning from the lungs mixes with deoxygenated systemic blood in the right heart. An atrial septal defect (ASD) must coexist for survival, allowing some oxygenated blood to reach the left heart. TAPVR is classified by anatomical drainage type: supracardiac (45%), cardiac (25%), infracardiac (25%), and mixed (5%).

TAPVR is classified into four anatomical types by the pulmonary vein drainage site: supracardiac (45%) — draining to the superior vena cava via a vertical vein; cardiac (25%) — draining directly into the coronary sinus or right atrium; infracardiac (25%) — draining below the diaphragm to the portal vein or hepatic veins (most commonly obstructed); and mixed (5%) — draining to multiple sites simultaneously. Obstructed TAPVR (most common in infracardiac type) presents as severe pulmonary oedema and cyanosis in the first hours of life and is a cardiac surgical emergency. Unobstructed TAPVR may present more insidiously with mild cyanosis and failure to thrive.

All neonates diagnosed with TAPVR require surgical correction, typically in the neonatal period or early infancy. Timing is determined by clinical urgency. Infracardiac TAPVR (where pulmonary veins drain below the diaphragm) is almost always obstructed, presenting as a neonatal emergency with severe cyanosis, pulmonary hypertension, respiratory distress, and metabolic acidosis requiring immediate surgery — often within hours of diagnosis. Supracardiac and cardiac types may be less acutely obstructed, allowing stabilisation before planned surgery within days to weeks. Pre-operative echocardiography and cardiac CT define the anatomy and guide surgical planning.

All four TAPVR types require individualised surgical planning. Supracardiac TAPVR — the most common (45%) — where pulmonary veins drain to a vertical vein connecting to the brachiocephalic vein and SVC — allows some time for pre-operative stabilisation unless the vertical vein is compressed between the left pulmonary artery and left mainstem bronchus causing obstruction. Mixed TAPVR (pulmonary veins draining to multiple different sites) is the most complex and requires careful anatomical mapping. Neonates with TAPVR require prostaglandin E1 infusion to maintain the patent ductus arteriosus if right-to-left shunting is providing systemic cardiac output while surgery is arranged.

Repair is performed under cardiopulmonary bypass with hypothermic cardiac arrest (circulatory arrest or selective antegrade cerebral perfusion). Through a median sternotomy, the heart is arrested with cardioplegia. The common pulmonary venous confluence — a chamber behind the left atrium where the anomalous veins converge — is identified and a wide anastomosis is created between the confluence and the posterior left atrial wall. In the sutureless technique, the pericardium is sewn around the confluence opening without sutures on the pulmonary veins, reducing risk of post-operative pulmonary venous obstruction. The anomalous systemic venous connection is ligated and the ASD is closed with a patch. Surgery takes 3-5 hours.

All four pulmonary veins are identified and their confluence exposed. The confluence is incised along its full length and anastomosed widely to the posterior left atrial wall using running sutures (typically 6/0 PDS). The anomalous vertical vein or coronary sinus connection is ligated. The atrial septal defect (ASD) is closed primarily or with a pericardial patch. De-airing manoeuvres and declamping of the aorta allow the heart to resume beating. Operative time is typically 2–4 hours. The completed anastomosis is assessed by direct inspection and transesophageal echocardiography (TEE) to confirm unobstructed pulmonary venous flow into the left atrium before separation from bypass.

Surgical correction is curative in the majority of cases. Five-year survival after TAPVR repair at experienced paediatric cardiac centres is 85-95% for non-obstructed types and 75-90% for obstructed infracardiac TAPVR with timely intervention. Normal cardiac function with physiologically correct pulmonary venous drainage to the left atrium is restored immediately after repair. Early surgical correction prevents irreversible pulmonary vascular disease from long-standing mixing and elevated pulmonary arterial pressure, preserving long-term lung function and normal growth and development.

Surgical correction of TAPVR is curative — unlike single ventricle palliation, the repair restores a normal two-ventricle circulation with four-chamber anatomy. Left ventricular growth after TAPVR repair is excellent in most infants: the decompressed left heart receives normal pulmonary venous return and grows rapidly in the post-operative period. Long-term cardiac function is normal in the majority of survivors without pulmonary venous obstruction. Return to normal childhood activities including sport is achievable for most TAPVR survivors by school age, with lifelong cardiology follow-up but generally excellent quality of life.

Pulmonary venous obstruction (PVO) after repair is the most feared complication, occurring in 10-20% of cases, most commonly with infracardiac type or suture-line narrowing. PVO causes progressive pulmonary hypertension and may require redo surgery, transcatheter balloon dilation, or sutureless reoperation. The sutureless technique has been developed specifically to reduce PVO recurrence. Other peri-operative risks include low cardiac output syndrome, arrhythmia (particularly junctional ectopic tachycardia), chylothorax, phrenic nerve injury, and infection. Neurodevelopmental outcomes are monitored long-term given the use of deep hypothermic circulatory arrest in neonates.

Pulmonary hypertensive crises — acute episodes of severe pulmonary hypertension with right heart failure — can occur in the first 24–72 post-operative hours and are managed with inhaled nitric oxide, sildenafil, and sedation/neuromuscular blockade to prevent triggering stimuli. Sinus node dysfunction from injury to the sinus node artery during repair occurs in 5–10%, manifesting as junctional rhythm or sinus bradycardia requiring temporary or permanent pacing. Chylothorax (lymph leak into the chest) occurs in 5–8% and requires dietary modification (medium-chain triglyceride diet) or octreotide treatment, occasionally requiring thoracic duct ligation.

Neonates are managed in the paediatric cardiac intensive care unit for 1-2 weeks post-operatively, requiring mechanical ventilation, vasopressor support, and careful fluid management. Chest drains are removed after 2-4 days. Echocardiography is performed before ICU discharge to confirm pulmonary venous flow is unobstructed. Hospital discharge typically occurs at 2-4 weeks. Cardiology follow-up with echocardiography every 3-6 months for the first 2 years is essential to detect recurrent pulmonary venous obstruction. Most survivors with unobstructed repair lead normal lives with no activity restriction. Long-term neurodevelopmental follow-up is recommended given exposure to cardiopulmonary bypass in the neonatal period.

After discharge, infants are reviewed at 1 month, 3 months, 6 months, and annually for life. Echocardiography monitors for pulmonary venous obstruction, anastomotic narrowing, and left ventricular function during the first critical year. Neurodevelopmental assessment at 18 months and school entry evaluates any cognitive or motor delays from the neonatal period of cyanosis and cardiopulmonary bypass. Most TAPVR children require no long-term medications if repair is uncomplicated, attending mainstream school with full activity participation.